In October, due to demand from existing healthcare partners, CTS began testing blood donors for antibody to Babesia microti under an Investigational New Drug exemption as a release test.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROSĀ® testing platform to perform COVID-1...